´¿¶­©ú Âå®v Ngan-Ming Tsang

ÀYÀV³¡¸~½F¡B»ó«|Àù¡B®ø¤Æ¨t²ÎÀù¡B¨xÀù¡B¤j¸zª½¸zÀù

Head and neck cancers, Nasopharyngeal cancer, Gastrointestinal tumors, Hepatoma, Colorectal cancers

¬ü°ê©ñ®g¸~½F¾Ç·|

American Association of Cancer Research (AACR)

¥xÆW©ñ®g¸~½F¾Ç·|

Taiwan Society for Therapeutic Radiology and Oncology

1. Publications:
   First or corresponding authorship after 2002: [SCI]

   1. Ngan-Ming Tsang, Kai-Ping Chang, Shinn-Yn Lin, Sheng-Po Hao, Chen-Kan Tseng, Tseng-tong Kuo, Ming-Hsui Tsai, Tsao-Chuen Chung. (2003) Detection of Epstein-Barr Virus-Derived Latent Membrane Protein-1 Gene in Various Head and Neck Cancers: Is It Specific for Nasopharyngeal Carcinoma? Laryngoscope. 113:1050-1054. [SCI] 1.752
   2. Tsang NM, Chuang CC, Tseng CK, Hao SP, Kuo TT, Lin CY, Pai PC. (2003) Presence of the latent membrane protein 1 gene in nasopharyngeal swabs from patients with mucosal recurrent nasopharyngeal carcinoma. Cancer. 98:2385-2392. [SCI] 4.771
   3. Leung WM, Tsang NM*, Chang FT, Lo CJ. (2005) Lhermitte's sign among nasopharyngeal cancer patients after radiotherapy. Head Neck. 27(3):187-94. [SCI] 2.403
   4. Lin SY, Chang KP, Hsieh MS, Ueng SH, Hao SP, Tseng CK, Pai PC, Chang FT, Tsai MH, Tsang NM*. (2005) The time frame of EPSTEIN-BARR virus latent membrane protein-1 gene to disappear in nasopharyngeal swabs after initiation of primary radiotherapy is an independently significant prognostic factor predicting local control for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 63(5):1339–1346. [SCI] 4.105
   5. Chang KP, Hao SP, Lin SY, Ueng SH, Pai PC, Tseng CK, Hsueh C, Hsieh MS, Yu JS, Tsang NM*. (2006) The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma. Laryngoscope. 116(4):541-546. [SCI] 1.752
   6. Pai PC, Tseng CK, Chuang CC, Wei KC, Hao SP, Hsueh C, Chang KP, Tsang NM* (2007). Polymorphism of C-terminal activation region 2 of Epstein-Barr virus latent membrane protein 1 in predicting distant failure and post-metastatic survival in patients with nasopharyngeal carcinoma. Head Neck. 29(2):109-19. [SCI] 2.403
   7. Tse KP, Tsang NM*, Chen KD, Li HP, Liang Y, Hsueh C, Chang KP, Yu JS, Hao SP, Hsieh LL, Chang YS (2007). MCP-1 Promoter Polymorphism at 2518 Is Associated with Metastasis of Nasopharyngeal Carcinoma after Treatment. Clin Cancer Res. 13(21):6320-6[SCI] 7.742
   8. Kai-Ping Chang, Ngan-Ming Tsang, Chun-Ta Liao; Cheng-Lung Hsu; Ming-Jui Chung; Chuan-Wei Lo, Sheng-Chieh Chan, Shu-Hang Ng, Hung-Ming Wang, Tzu-Chen Yen, (2012) Prognostic significance of 18F-FDG PET parameters and plasma EBV DNA load in patients with nasopharyngeal carcinoma. J Nucl Med. J Nucl Med. 2012 Jan;53(1):21-8. [SCI] 6.381  Erratum in: J Nucl Med. 2012 Feb;53(2):342.(First author: Drs. Kai-Ping Chang and Ngan-Ming Tsang contribute equally to this work.)
   9. Ping Ching Pai, Chi Cheng Chuang, Chen Kan Tseng, Ngan Ming Tsang*, Kai Ping Chang, Tzu Chen Yen, Chun Ta Liao, Ji Hong Hong, Joseph Tung Chieh Chang. (2012) Impact of pre-treatment body mass index on patients with head and neck cancer treated with radiation. Int J Radiat Oncol Biol Phys. Vol. 83, No. 1, pp. e93-e100, 2012. [SCI] 4.105
   10. Ka-Po Tse, Chi-Sheng Wu, Chuen Hsueh, Kai-Ping Chang, Sheng-Po Hao, Yu-Sun Chang and Ngan-Ming Tsang*. (2012) The Relationship between Secretory Leukocyte Protease Inhibitor Expression and Epstein-Barr Virus Status among Patients with Nasopharyngeal Carcinoma. Anticancer ResearchApril 2012 vol. 32 no. 4 1299-1307. [SCI] 1.725
   11. Yueh-Hsiang Huang, Jiun-Liang Chen, Geng-Hao Liu, Sien-Hung Yang, Kai-Ping Chang, and Ngan-Ming Tsang*. (2013) Influence of Chinese Medicine on Weight Loss and Quality of Life During Radiotherapy in Head and Neck Cancer. Integrative Cancer Therapies 2013 vol. 12 no. 1 41-49. [SCI] 2.136

   Co authorship after 2002: [SCI]

   1. Yueh-Hsiang Huang, Jiun-Liang Chen, Geng-Hao Liu, Sien-Hung Yang, Kai-Ping Chang, and Ngan-Ming Tsang*. (2012) Influence of Chinese Medicine on Weight Loss and Quality of Life During Radiotherapy in Head and Neck Cancer. Integrative Cancer Therapies 2012 May 2 [SCI] 2.136
   2. Dai TS, Hao SP, Chang KP, Pan WL, Yeh HC, Tsang NM. (2003) Complications of mandibulotomy: Midline versus paramidline. Otolaryngol Head Neck Surg. 128:137-141.  [SCI] 1.718
   3. Hao SP, Tsang NM, and Chang KP (2003). Screening nasopharyngeal carcinoma by detection of the latent membrane protein 1 (LMP-1) gene with nasopharyngeal swabs. Cancer. 15:1909-1913. [SCI] 4.771
   4. Hao SP, Tsang NM, Chen YL, Chang KP, Su JL. (2003) Detection of LMP-1 gene in middle ear effusion of NPC. Oral Oncol. 39(3):296-300. [SCI] 2.857
   5. Chen Kan Tseng, Ng Ming Tsang, Kuo Chen Wei, Tang Her Jaing, Ping Chin Pai and Tung Chien Chang. (2003) Radiotherapy to primary CNS germinoma: how large an irradiated volume is justified for tumor control? Journal of nruro-oncology 62:343-348. [SCI] 3.214
   6. Chen MF, Chang JT, Tsang NM, Liao CT, Chen WC. (2003)  Radiotherapy of early-stage glottic cancer: analysis of factors affecting prognosis.  Ann Otol Rhinol Laryngol. 112: 904-911.  [SCI] 1.048
   7. Chuang CC, Chang CN, Tsang NM, Wei KC, Tseng CK, Chang JT, Pai PC. (2004) Linear accelerator-based radiosurgery in the management of skull base meningiomas. J Neurooncol. 66:241-249. [SCI] 3.214
   8. Pai PC, Tsang NM, Tseng CK, Hao SP, Kuo TT, Wei KC, Hsueh C, Chuang CC. (2004) Prevalence of LMP-1 gene in tonsils and non-neoplastic nasopharynxes by nest-polymerase chain reaction in Taiwan. Head Neck. 26(7):619-24. [SCI] 2.403
   9. Chang KP, Hao SP, Tsang NM, Ueng SH. (2004) Salvage surgery for locally recurrent nasopharyngeal carcinoma-A 10-year experience.  Otolaryngol Head Neck Surg. 131(4):497-502. [SCI] 1.718
   10. Wang HM, Liao CT, Chang TC, Chen JS, Liaw CC, Chen IH, Tsang NM. (2004) Biweekly paclitaxel, cisplatin, tegafur, and leucovorin as neoadjuvant chemotherapy for unresectable squamous cell carcinoma of the head and neck. Cancer. 15;101(8):1818-23.  [SCI] 4.771
   11. Kuo TT, Shih LY, Tsang NM. (2004) Nasal NK/T Cell Lymphoma in Taiwan: A Clinicopathologic Study of 22 Cases, with Analysis of Histologic Subtypes, Epstein-Barr Virus LMP-1 Gene Association, and Treatment Modalities. Int J Surg Pathol. 12(4):375-87.  [SCI] 1.000
   12. Hao SP, Tsang NM, Chang KP. (2004) Monitoring Tumor Recurrence with Nasopharyngeal Swab and Latent Membrane Protein-1 and Epstein-Barr Nuclear Antigen-1 Gene Detection in Treated Patients with Nasopharyngeal Carcinoma. Laryngoscope. 114(11):2027-2030. [SCI] 1.752
   13. Hao SP, Tsang NM, Chang KP, Ueng SH. (2004) Molecular diagnosis of nasopharyngeal carcinoma: Detecting LMP-1 and EBNA by nasopharyngeal swab. Otolaryngol Head Neck Surg. 131(5):651-4. [SCI] 1.718
   14. Chu PH, Jung SM, Lin HC, Yeh CH, Wu HH, Shiu TF, Huang SL, Tseng NM, Chu JJ, Lin PJ, Lai CH. (2005) Caspase-3-dependent apoptosis in cardiac myxoma: not associated with human papillomavirus or Epstein-Barr virus. Mod Pathol. 18:822-827.  [SCI] 4.792
   15. Wu CC, Chien KY, Tsang NM, Chang KP, Hao SP, Tsao CH, Chang YS, Yu JS. (2005) Cancer cell-secreted proteomes as a basis for searching potential tumor markers: Nasopharyngeal carcinoma as a model. Proteomics.  5:3173-3182. [SCI]  4.505
   16. Hao SP, Tsang NM, Chang KP, Chen CK, Huang SS (2006). Treatment of squamous cell carcinoma of the retromolar trigone. Laryngoscope. 116(6):916-920. [SCI] 1.752
   17. Hsueh C, Kuo TT, Tsang NM, Wu YC, Yang CP, Hung IJ (2006). Thymic Lymphoepithelioma like Carcinoma in Children: Clinicopathologic Features and Molecular Analysis. J Pediatr Hematol Oncol. 28(12):785-790. [SCI] 1.159
   18. Chang KP, Hao SP, Tsang NM, Chang YL, Cheng MH, Liu CT, Lee YS, Tsai CL, Lee TJ, Wang TH, Tsai CN (2008).  Gene expression and promoter polymorphisms of DNA methyltransferase 3B in nasopharyngeal carcinomas in Taiwanese people: A case-control study. Oncol Rep. Jan; 19(1):217-22. [SCI] 1.835
   19. Chang KP, Hsu CL, Chang YL, Tsang NM, Chen CK, Lee TJ, Tsao KC, Huang CG, Chang YS, Yu JS, Hao SP  (2008). Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: A possible alternative for primary screening of nasopharyngeal carcinoma. Oral Oncol. 2008 Jan 16. [SCI] 2.857
   20. Hao SP, Tsang NM, Chang KP, Hsu YS, Chen CK, Fang KH. (2008) Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 53 patients and prognostic factors. Acta Otolaryngol.128(4):473-81. [SCI] 1.084
   21. Chen LC, Hsueh C, Tsang NM, Liang Y, Chang KP, Hao SP, Yu JS, Chang YS. (2008) Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma. Clin Cancer Res. 15; 14(12):3807-13. [SCI]  7.742
   22. Lin JD, Lin KJ, Chao TC, Hseuh C, Tsang NM. (2008) Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0. Radiother Oncol. 89:97-104. [SCI] 5.580
   23. Wu CC, Peng PH, Chang YT, Huang YS, Chang KP, Hao SP, Tsang NM, Yeh CT, Chang YS, Yu JS. (2008) Identification of potential serum markers for nasopharyngeal carcinoma from a xenografted mouse model using Cy-dye labeling combined with three-dimensional fractionation. Proteomics. Sep;8(17):3605-20. [SCI] 4.505
   24. Chang KP, Hao SP, Chang JH, Wu CC, Tsang NM, Lee YS, Hsu CL, Ueng SH, Liu SC, Liu YL, Wei PC, Liang Y, Chang YS, Yu JS. (2008) Macrophage Inflammatory Protein-3{alpha} Is a Novel Serum Marker for Nasopharyngeal Carcinoma Detection and Prediction of Treatment Outcomes. Clin Cancer Res. Nov 1;14(21):6979-87. [SCI] 7.742
   25. Chu PH, Jung SM, Yeh CH, Wu HH, Shiu TF, She HC, Tsang NM. (2008) Expression of caspase-3-dependent apoptosis in mural thrombi leukocytes. APMIS. 116: 995-999. [SCI] 0.508
   26. Tse KP, Su WH, Chang KP, Tsang NM, Yu CJ, Tang P, See LC, Hsueh C, Yang ML, Hao SP, Li HY, Wang MH, Liao LP, Chen LC, Lin SR, Jorgensen TJ, Chang YS, Shugart YY. Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am J Hum Genet. 2009 Aug;85(2):194-203. [SCI] 10.603
   27. Hsin LJ, Fang TJ, Chang KP, Fang KH, Tsang NM, Chen YL, Jung SM, Yeh AR, Hao SP.  (2009) Transoral endoscopic CO2 laser microsurgery for early laryngeal cancers. Chang Gung Med J. 2009 Sep-Oct;32(5):517-25. Àu¨}´Á¥Z
   28. Fang KH, Kao HK, Cheng MH, Chang YL, Tsang NM, Huang YC, Lee LY, Yu JS, Hao SP, Chang KP. (2009)  Histological differentiation of primary oral squamous cell carcinomas in an area of betel quid chewing prevalence. Otolaryngol Head Neck Surg. 2009 Dec;141(6):743-9. [SCI] 1.718
   29. Wei KC, Huang CY, Chen PY, Feng LY, Wu TW, Chen SM, Tsai HC, Lu YJ, Tsang NM, Tseng CK, Pai PC, Shin JW. Evaluation of the prognostic value of CD44 in glioblastoma multiforme. Anticancer Res. 2010 Jan;30(1):253-9. [SCI] 1.725
   30. Chen CC, Chen LC, Liang Y, Tsang NM, Chang YS. Epstein-Barr virus latent membrane protein 1 induces the chemotherapeutic target, thymidine phosphorylase, via NF-kappaB and p38 MAPK pathways. Cell Signal. 2010 Jul;22(7):1132-42. [SCI] 4.058
   31. Chang KP, Wu CC, Chen HC, Chen SJ, Peng PH, Tsang NM, Lee LY, Liu SC, Liang Y, Lee YS, Hao SP, Chang YS, Yu JS. Identification of candidate Nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: potential usage of cystatin a for predicting nodal stage and poor prognosis. Proteomics. 2010 Jul;10(14):2644-60. [SCI] 4.505
   32. Chen LC, Chung IC, Hsueh C, Tsang NM, Chi LM, Liang Y, Chen CC, Wang LJ, Chang YS. The antiapoptotic protein, FLIP, is regulated by heterogeneous nuclear ribonucleoprotein K and correlates with poor overall survival of nasopharyngeal carcinoma patients. Cell Death Differ. 2010 Sep;17(9):1463-73. [SCI] 8.849
   33. Chen LC, Chen CC, Liang Y, Tsang NM, Chang YS, Hsueh C. A novel role for TNFAIP2: its correlation with invasion and metastasis in nasopharyngeal carcinoma. Mod Pathol. 2010 Feb;24(2):175-84. [SCI] 4.792
   34. Hsueh C, Chang YS, Tseng NM, Liao CT, Hsueh S, Chang JH, Wu IC, Chang KP. Expression pattern and prognostic significance of claudins 1, 4, and 7 in nasopharyngeal carcinoma. Hum Pathol. 2010 Jul;41(7):944-50. [SCI] 2.876
   35. Tseng CK, Tsang NM, Jaing TH, Liau CT, Wu CT, Lin KL. Outcome of central nervous system germinoma treatment by chemoradiation. J Pediatr Hematol Oncol. 2011 May;33(4):e138-42. [SCI] 1.159
   36. Lin JD, Lin KJ, Chao TC, Hseuh C, Tsang NM. Clinical presentations of thyroid cancer patients with multiple primary cancers. J Endocrinol Invest. 2011 Dec;34(11):824-30. [SCI] 1.566
   37. Chang KP, Chang YT, Wu CC, Liu YL, Chen MC, Tsang NM, Hsu CL, Chang YS, Yu JS. Multiplexed immunobead-based profiling of cytokine markers for detection of nasopharyngeal carcinoma and prognosis of patient survival. Head Neck. 2011 Jun;33(6):886-97. [SCI] 2.403
   38. Huang BY, Lin JD, Chao TC, Lin KJ, Hseuh C, Tsang NM. Therapeutic Outcomes of Papillary Thyroid Cancer Patients in Different Risk Groups. Oncology. 2011 Jun 14;80(1-2):123-129. [SCI] 2.267
   39. Tse KP, Su WH, Yang ML, Cheng HY, Tsang NM, Chang KP, Hao SP, Yao Shugart Y, Chang YS. A gender-specific association of CNV at 6p21.3 with NPC susceptibility. Hum Mol Genet. 2011 Jul 15;20(14):2889-96. [SCI] 7.636
   40. Hsu CL, Chang KP, Lin CY, Chang HK, Wang CH, Lin TL, Liao CT, Tsang NM, Lee LY, Chan SC, Ng SH, Li HP, Chang YS, Wang HM. Plasma epstein-barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma. Head Neck. 2011 Nov 15. [SCI] 2.403
   41. Wang LJ, Hsu CW, Chen CC, Liang Y, Chen LC, Ojcius DM, Tsang NM, Hsueh C, Wu CC, Chang YS. Interactome-wide analysis identifies end-binding protein 1 as a crucial component for the speck-like particle formation of activated AIM2 inflammasomes. Mol Cell Proteomics. 2012 Aug 6. [SCI] 7.398
   42. Hsueh C, Lin JD, Yang CF, Chang YS, Chao TC, Sun JH, Wu IC, Tseng NM, Ueng SH. Prognostic significance of Tiam1 expression in papillary thyroid carcinoma. Virchows Arch. 2011 Dec;459(6):587-93. [SCI] 2.491
   43. Hsu WL, Tse KP, Liang S, Chien YC, Su WH, Yu KJ, Cheng YJ, Tsang NM, Hsu MM, Chang KP, Chen IH, Chen TI, Yang CS, Goldstein AM, Chen CJ, Chang YS, Hildesheim A. Evaluation of Human Leukocyte Antigen-A (HLA-A), Other Non-HLA Markers on Chromosome 6p21 and Risk of Nasopharyngeal Carcinoma. PLoS One. 2012;7(8):e42767. [SCI] 4.092
   44. Wang LJ, Hsu CW, Chen CC, Liang Y, Chen LC, Ojcius DM, Tsang NM, Hsueh C, Wu CC, Chang YS. Interactome-wide analysis identifies end-binding protein 1 as a crucial component for the speck-like particle formation of activated AIM2 inflammasomes. Mol Cell Proteomics. 2012 Aug 6. [SCI] 7.398
   45. Chen LC, Wang LJ, Tsang NM, Ojcius DM, Chen CC, Ouyang CN, Hsueh C, Liang Y, Chang KP, Chen CC, Chang YS. Tumour inflammasome-derived IL-1β recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma. EMBO Mol Med. 2012 Dec;4(12):1276-93.
   46. Hsueh C, Lin JD, Chang YS, Hsueh S, Chao TC, Yu JS, Jung SM, Tseng NM, Sun JH, Kuo SY, Ueng SH. Prognostic significance of pituitary tumor-transforming gene-binding factor (PBF) expression in papillary thyroid carcinoma. Clin Endocrinol (Oxf). 2013 Feb;78(2):303-9. [SCI] 3.168
   47. Hsu CL, Chan SC, Chang KP, Lin TL, Lin CY, Hsieh CH, Huang SF, Tsang NM, Lee LY, Ng SH, Wang HM. Clinical scenario of EBV DNA follow-up in patients of treated localized nasopharyngeal carcinoma. Oral Oncol. 2013 Mar 2. [SCI] 2.857

   First or corresponding authorship after 2002: [non-SCI]

   1. ´¿¶­©ú¡B­Sºõ¦æ¡B¥Õ¦B²M¡B ½²¤¶¥Í¡B ªL­Å?¡B ³¯¦Ú­b¡B ´¿®¶²h¡B ³¯¥ÉµÓ¡C (2003) ©T©w²`«×ªvÀø¹ïª½¸z¨zªùÀù©ñ®gªvÀøªº¼vÅT¡C ©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤Q¨÷²Ä¤@´Á²Ä37-44­¶¡C
   2. ¶À·N´@¡B¥Õ¦B²M¡B´¿®¶²h¡B¬x§Ó§»¡B´¿¶­©ú*¡C(2003) »ó«|Àù¯f±w±µ¨üÅé¥~©ñ®gªvÀø-§½³¡ªvÀø¾¯¶q4500cGy¥H¤Uµ²ªG¤§°Q½×¡C ©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤Q¨÷²Ä¤G´Á²Ä63-68­¶¡C
   3. ³¯¥ÉµÓ¡B´¿®¶²h¡B´ö°ê¬F¡B¬x§Ó§»¡B´¿¶­©ú*¡C(2003)©ñ®gªvÀø¤§Àù±w¹ï­¹ª«¸T§Òªº½Õ¬d¡C ©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤Q¨÷²Ä¤T´Á²Ä137-140­¶¡C
   4. ­Sºõ¦æ¡B´¿®¶²h¡B¥Õ¦B²M¡B´¿¶­©ú*¡B¬x§Ó§»¡C(2003)¤p©ó40·³ªº¦ÞÀù±wªÌ¤§ªvÀøµ²ªG¡C©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤Q¨÷²Ä¥|´Á²Ä219-228­¶¡C
   5. ³¯«Û¶W¡B´¿¶­©ú*¡B±i´I­}¡B¬x§Ó§»¡C(2005) ¨zªùÃþ¤W¥ÖÀù©ó³æ¤@ÂåÀø°|©Ò¤§ªvÀø¦¨ªG¡C©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤Q¤G¨÷²Ä¤@´Á²Ä17-25­¶¡C
   6. ¶À¬±³Ó¡B¬x§Ó§»¡B¥Õ¦B²M¡B¤ý«T³Ç¡B´¿¶­©ú*¡C(2008) ¥¼·P¬V epstein-Barr ¯f¬r¤§ÀYÀV³¡­ìµo³¡¦ì¤£©úÀù¯gªvÀøµ²ªG¡C©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤Q¤­¨÷²Ä¤G´Á²Ä91-100­¶¡C
   7. ¬x©v¥Á¡B¬x§Ó§»¡B±ç¬°¥Á¡BªL­Å?¡B¸â³»¥ß¡B´¿¶­©ú*¡C(2009) ©ñ®g½uªvÀø¹ï©ó¦³¨xªù«I¥Ç¥B°ªÁx¬õ¯Àªº±ß´Á¨xÀù¡GªvÀø«áÁx¬õ¯À¤U­°¦³¸û¨Îªº¦s¬¡²v¡C©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤Q¤»¨÷²Ä¤T´Á²Ä179-194­¶¡C
   8. ³¯¦Ú­b¡B«À¾ÇµØ¡B½²¤¶¥Í¡B¬x§Ó§»¡B³¯«Û¶W¡B­Sºõ¦æ¡BªL«T«Û¡B´¿¶­©ú*¡C(2009) ©ñ®gªvÀøÂåÀø¸ê°T¨t²ÎARIATM«È»s¤Æ©ñ®gªvÀøªvÀø¬ö¿ý³æ¡C©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤Q¤»¨÷²Ä¤T´Á²Ä215-226­¶¡C
   9. ¼B¸q¸Û¡B¼B·Ø¹ü¡B³¯¬f¤¸¡B³¯¦Ú­b¡B±i¦w¶i¡Bµ{¨¥¹©¡B´¿¶­©ú*¡B¬x§Ó§»¡C(2010) §Q¥Î¼v¹³¾É¤Þ©ñ®gªvÀø§Þ³N¨Óµû¦ôÂ\¦ì»~®t¹ï©ó­p¹º¹vÅé¿n¥]Âвvªº¼vÅT¡C©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤Q¤C¨÷²Ä¤G´Á²Ä215-226­¶¡C
   10. ³¯¥ÉµÓ¡B´¿®¶²h¡B¬x§Ó§»¡B´¿¶­©ú*¡C(2011) Âå°|ªA°È«~½è»PÅU«È»ù­È¹ï©óÀù±wº¡·N«×ªºÃö«Y±´°Q¡C©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤Q¤K¨÷²Ä¥|´Á²Ä287-297­¶¡C
   11. ªL¤h±Ó¡BªL«H§u¡B¬x§Ó§»¡B´¿¶­©ú*¡C(2012) ¦bª½¸zÀù¯f±w¤ñ¸û¨âºØ³N«e»²§UªvÀøµ²ªG¡G¦^·¹©Ê¬ã¨s¤Î±´°Q¶i¦æ¼Ð·Ç¤â³N¤§­«­n©Ê¡C©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤Q¤E¨÷²Ä¤G´Á²Ä1-9­¶¡C
   12. ¨H«³¨}¡BªL«H§u¡B¬x§Ó§»¡B¥Õ¦B²M¡BªL­Å?¡B´¿®¶²h¡B´¿¶­©ú*¡C(2012) ©ñ®gªvÀø«e«áÅé­«´î»´µ{«×≥5%»P»ó«|Àù¯f¤Hªº¾ãÅé¦s¬¡²v¤§¶¡¦s¦b¥¿¬ÛÃö©Ê¡C©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤Q¤E¨÷²Ä¤T´Á²Ä167-179­¶¡C

    

   Co authorship after 2002: [non-SCI]

   1. ±i´I­}¡B´¿¶­©ú¡B±`¦ö±d¡B±ç¬°¥Á¡C (2004) Áx¹DÀù©ñ®g½uªvÀø«á¤§¦s¬¡²v¥H¤Î§½³¡±±¨î  ©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä11¨÷²Ä¤T´Á²Ä133-140­¶.
   2. ³¯¥ÉµÓ¡B´¿®¶²h¡B³¯¬ü§D¡B¬x§Ó§»¡B´¿¶­©ú¡B§õ¥°·u¡C(2005)©ñ®gªvÀø¤§´c©Ê¸£½F±wªÌ±µ¨ü¥tÃþÀøªk»P­¹ª«Æ[©Àªº½Õ¬d¤ÀªR¡C©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤Q¤G¨÷²Ä¤@´Á²Ä59-65­¶¡C
   3. Hao SP, Tsang NM, Chang KP, Chen CK, Chao WC (2007). Osteoradionecrosis of external auditory canal in nasopharyngeal carcinoma. Chang Gung Med J. 30(2):116-21.
   4. ³¯¥ÉµÓ¡B´¿®¶²h¡B´¿¶­©ú¡B¬x§Ó§»¡C(2008) ©ñ®g¸~½FÀù±w±µ¨ü¦èÂå¡B¤¤Âå»P¥tÃþÀøªkªº¬ÛÃö©Ê½Õ¬d¤ÀªR¡C©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤Q¤­¨÷²Ä¥|´Á²Ä289-300­¶¡C
   5. ¸â³»¥ß¡B¬x§Ó§»¡B´¿¶­©ú¡B³¯§Ó»¨¡BªL«H§u¡C(2009)°w¹ï¦óªNª÷¤ó²O¤Ú½F¯f¤H±µ¨ü©ñ®gªvÀøªºµ²ªG¤Î´_µo¼Ò¦¡¤§ªø´Á¦^·¹©Ê¬ã¨s¡G³æ¤@Âå°|ªº¸gÅç¡C©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤Q¤»¨÷²Ä¤G´Á²Ä85-97­¶¡C
   6. ³¢ÅD­i¡B´¿¶­©ú¡B¸­±Ò·½¡B¬x§Ó§»¡C(2009)¤ì§ø¤ó¯gªº©ñ®g½uªvÀø¡G¤T¦ì¯f¤H¸gÅç³ø§i¤Î¤åÄm¦^ÅU¡C©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤Q¤»¨÷²Ä¤G´Á²Ä143-150­¶¡C
   7. Hao SP, Tsang NM. (2010) Surgical management of recurrent nasopharyngeal carcinoma. Chang Gung Med J. 2010 Jul-Aug;33(4):361-9. Àu¨}´Á¥Z
   8. °ª¨Ì¦|¡B³¯©É´@¡B±iùÚÂE¡B·¨½åÂE¡B§d©yÂE¡B³¢©¾ºÕ¡B³ì¸tµY¡B­J­Å´@¡B´¿¶­©ú¡B³¯«T¨}¡C(2009) ¥ÕªéĪîP¾®½¦ªvÀø«æ©Ê©ñ®g©Ê¥Ö½§ª¢ªºÀø®ÄÆ[¹î¡C¤W®ü¤¤ÂåÃĤj¾Ç¾Ç³ø¡C²Ä¤G¤Q¤T¨÷²Ä¤G´Á²Ä37-39­¶¡C
   9. ³¯¬f¤¸¡Bµ{¨¥¹©¡BªL¨Î¥Í¡BªL«T«Û¡B±i¦w¶i¡B¼B¸q¸Û¡B´¿¶­©ú¡B¬x§Ó§»¡C(2010)§Q¥Î©ñ®gªvÀø¼v¹³¾É¤Þ¨t²Îµû¦ô´Ó¤Jª÷ÄݼаOÄáÅ@¸¢Àù¯f±w¤§Â\¦ì»~®t¤ÎªvÀø¤¤»~®t¡C¤¤µØ©ñ®g½u§Þ³N¾ÇÂø»x²Ä244-251­¶¡C

   Publications before 2002:

   1. Tsang, N. M.*, and Lin, F.J. (1987).  Treatment of Recurrent Cervical Cancer.  Chang Gung Med. J. 10, 202-210. Àu¨}´Á¥Z [*Corresponding author]
   2. T Tsang, N. M.*, Leung, W., and Lin, F.J. (1987).  Post Operative Radiation Therapy of Rectal and Sigmoid Colon Cancer Patients under 40 Years of Age. ¤¤µØ©ñ®g½uÂå¾ÇÂø»x ²Ä12¨÷²Ä227-232­¶¡C [*Corresponding author]
   3. Nagasawa, H., Little, J. B., Tsang, N. M., Saunders, E., Tesmer, J., and Strniste, G. F. (1992).  Effect of Dose Rate on the Survival of Irradiated Human Skin Fibroblasts.  Radiat. Res. 132, 375-379. [SCI]
   4. Tsang, N. M. (1994).  Retinoblastoma and p53 Gene Expression and Radiosensitivity in vitro.  (Thesis)  Harvard School of Public Health.  Boston, Massachusetts.
   5. Tsang, N. M. and Little, J. B. (1994).  Effect of Restoration of Retinoblastoma Gene Function on the Radiosensitivity of Cells of Human Tumor Cell Lines.  Radiat. Res. 140, 172-179. [SCI]
   6. Tsai, C.S., Ho, Y.S., Tang, S. G., Lin, F.J., Leung, W.M., Chen, L.H. and Tsang, N. M. (1994).  Postoperative Irradiation in the Treatment of Brain Oligodendroglioma. ¤¤µØ©ñ®g½uÂå¾ÇÂø»x ²Ä19¨÷²Ä297-305­¶¡C
   7. Li, C., Nagasawa, H., Tsang, N. M., and Little, J. B. (1995).  Radiation-induced Irreversible G(0)/G(1) Block is Abolished in Human Diploid Fibroblasts Transfected with the Human Papilloma Virus E6 Gene: Implication of the p53-Cip1/WAF1 Pathway.  Int. J. Oncol. 6, 233-236. [SCI]
   8. Xia, F., Wang, X., Wang, Y. H., Tsang, N. M., Yandell, D. W., Kelsey, K. T., and Liber, H. L. (1995).  Altered p53 Status Correlates with Differences in Sensitivity to Radiation-induced Mutation and Apoptosis in Two Closely Related Human Lymphoblast Lines.  Cancer Res. 55, 12-15. [SCI]
   9. Tsang, N. M., Nagasawa, H., Li, C., and Little J. B. (1995).  Abrogation of p53 Function by Transfect ion of HPV16 E6 Gene Enhances the Resistance of Human Diploid Fibroblasts to Ionizing Radiation.  Oncogene 10, 2403-2408. [SCI]   
   10. ´¿®¶²h¡B´¿¶­©ú*¡B¼B¤d¦p¡B ³¯¥ÉµÓ¡B´ö°ê¬F (1996).  »ó«|Àùªº»·ºÝÂಾ¡C  ©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤T¨÷ ²Ä229-232­¶¡C [*Corresponding author]
   11. ³¯¥ÉµÓ¡B´¿¶­©ú*¡B´¿®¶²h¡B³¯¤å¬F¡B ±ç¬°¥Á¡B´ö°ê¬F¡C(1996) 16¦~»ó«|ÀùÀù¯fµn°O¡C©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤T¨÷ ²Ä233-237­¶¡C[*Corresponding author]
   12. Pai, P.C., Tsang, N. M.*, Liu, C.J., Lee S.T., and Tang, S.G. J. (1997).  Radiosurgery and Multiple Co-planar Fields in the Treatment of Recurrent Nasopharyngeal Cancer – A Case Report.  ©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¥|¨÷²Ä65-69­¶¡C [*Corresponding author]
   13. Lin, J.D., Tsang, N. M., Hung, M.J., and Weng, H.F. (1997).  Result of External Beam Radiotherapy in Patients with Well Differentiated Thyroid Carcinoma.  Jan. J. Clin. Onco. 27, 244-247. [SCI]
   14. ¬xºÓ¾±¡B´¿¶­©ú* (1997).  ¤â³N¤¤©ñ®gªvÀø¬I©ñ¾¹¤§³]­p.  ©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¥|¨÷²Ä281-284­¶¡C [*Corresponding author] 
   15. ³¯¥ÉµÓ¡B´¿¶­©ú*¡B´¿®¶²h¡B ¬x§Ó§»¡C (1997)»ó«|Àù¯f±w©ñ®gªvÀø¤¤Â_ªº­ì¦]¤Î¤ÀªR¡C©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¥|¨÷²Ä251-257­¶¡C [*Corresponding author]
   16. Tseng, C.K., Tsang, N. M.*, Kao, S.H., Chen, S.Y., and Chen, Y.P. (1998).  Technical Report: A Quick Method to Extract DNA from Paraffin-embedded Tissues.  Chang Gung Med. J. 21, 63-66.  Àu¨}´Á¥Z[*Corresponding author] (NSC-85-2332-B-182A-053)
   17. Lin, S. Y., Tsang, N. M.*, Tsai, C. S., Chen, W. C., Tseng, C.K., Jeng, L. B., Jan, Y. Y., Yeh, T. S., Wang, C. S., Wang, J. Y., and Hung, J. H. (1998).  Intraoperative Radiation Therapy: The Preliminary Experience in Chang Gung Memorial Hospital.  ©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤­¨÷²Ä73-80­¶¡C [*Corresponding author]                  
   18. Lai, C. H., Wang, C. H., Tsang, N. M., and Hsueh, C. (1998).  Kadish Stage C Olfactory Neuroblastoma Successfully Treated by Chemoradiotherapy: Report of Two Cases. Chang Gung Med. J. 21, 487-492.  Àu¨}´Á¥Z
   19. Pai, P.C., Tsang, N. M.*, Tseng, C.K., Kao, L. Y., and Hung, J. H. (1998).   External Beam Radiotherapy for Non-Operative Retinoblastoma: A Retrospective Study. ©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤­¨÷²Ä149-156­¶¡C [*Corresponding author]
   20. Kao, L. Y. and Tsang, N. M. (1999).  Advanced Bilateral Retinoblastoma Treated Conservatively with Lens Sparing External Beam Radiation Therapy: Report of Three Cases. Chang Gung Med. J. 22, 100-105.  Àu¨}´Á¥Z
   21. Chen, W.C., Her, J. W., Yeh, J. Y., Hung, C. S., Hung, S. S., Lin, Y. C., Tsang, N. M., Leung, W. M., Tang, S. G, Hung, J. H., Tan, R., Lee, C. C. (1999).   Study of Treatment Variation in the Radiotherapy of Pelvic Tumors using a New Custom-Made Immobilization Cast and On-Line Electronic Portal Imaging.  ©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤­¨÷²Ä293-302­¶¡C
   22. ³¯¥ÉµÓ¡B´¿¶­©ú*¡B¬x§Ó§»¡B´ö°ê¬F¡B´¿®¶²h¡B³¯¤å¬F¡C(1999) »ó«|Àù©ñ®gªvÀø«á¥Ö½§·Ã©Ê²æ®hªº³B²z»P¤ÀªR¡C ©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤»¨÷²Ä¤@´Á²Ä41-48­¶¡C [*Corresponding author]
   23. ³¯¥ÉµÓ¡B´¿¶­©ú*¡B´¿®¶²h¡BªL«H§u¡B¬x§Ó§»¡C(1999) ©ñ®gªvÀø¤§Àù±w±µ¨ü¥tÃþÀøªkªº½Õ¬d¡C ©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤»¨÷²Ä¥|´Á²Ä295-300­¶¡C[*Corresponding author]
   24. Chang, J. T., See, L.-C., Liao, C.-T., Ng, S.-H., Wang, C.-H., Chen, I.-H., Tsang, N.-M., Tseng, C.-K., Tang, S. G., Hong, J.-H. (2000). Locally recurrent nasopharyngeal carcinoma. Radiother Oncol 54, 135-142. [SCI]   
   25. Chen YP, Tsang NM*, Tseng CK, Lin SY. (2000) Causes of interruption of radiotherapy in nasopharyngeal carcinoma patients in Taiwan. Jpn. J. Clin. Oncol. 30, 230-4. [SCI] [*Corresponding author]                                     
   26. Tang SG, See LC, Chen WC, Tsang S, Chang JT, Hong JH. (2000). The effect of nodal status on determinants of initial treatment response and patterns of relapse-free survival in nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 47, 867-873.      [SCI]
   27. Chang KP, Tsang NM, Chen CY, Su JL, Hao SP.  (2000). Endoscopic management of skull base osteoradionecrosis. Laryngoscope 110: 1162-1165. [SCI]
   28. Wang, C. C., Chen, M. L., Hsu, K. H., Lee, S. P., Chen, T. C., Chang, Y. S., Tsang, N. M., and Hung, J. H.  (2000). Second Malignant Tumors in Patients with Nasopharyngeal Carcinoma and Their Association with Epstein-Barr Virus.  Int. J. Cancer 15: 228-231.  [SCI]
   29. ±`¦ö±d¡B¥Õ¦B²M¡B³¯§®ªâ¡B´ö°ê¬F¡B±iªFªN¡B¬x§Ó§»¡B´¿¶­©ú*(2000) ¨u¨£¯f²z²Õ´§ÎºA»ó«|Àù¤§ªvÀøµ²ªG ©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤C¨÷²Ä¥|´Á²Ä259-265­¶. [*Corresponding author]
   30. Kuo T, Tsang NM.  (2001) Salivary gland type nasopharyngeal carcinoma: a histologic, immunohistochemical, and Epstein-Barr virus study of 15 cases including a psammomatous mucoepidermoid carcinoma. Am. J. Surg. Pathol.  25: 80-86. [SCI]
   31. Sung KF, Tsang NM, Tseng JH, Yeh CT. (2001) Effective relief of obstructive jaundice in a patient with nonresectable icteric-type hepatocellular carcinoma by external beam radiation therapy: case report. Chang Gung Med J 24:114-118. Àu¨}´Á¥Z
   32. Shinn-yn Lin, Ngan-ming Tsang*, Shu-ching Kao, Yu-ling Hsieh, Yu-ping Chen, Chien-sheng Tsai, Tseng-tong Kuo, Shing-po Hao, I-how Chen, and Ji-hong Hong.  (2001)  Presence of Epstein-Barr Virus Latent Membrane Protein 1 Gene in the Nasopharyngeal Swabs from Patients with Nasopharyngeal Carcinoma.  Head and Neck 23:194-200. [SCI] [*Corresponding author] (NSC89-2320-B-182A-031-M08)
   33. Hao SP, Tsang NM, and Chang KP.  (2001) Differentiation of Recurrent Nasopharyngeal Carcinoma and Skull Base Osteoradionecrosis by Epstein-Barr Virus-Derived Latent Membrane Protient-1 Gene. Laryngoscope 111:650– 652. [SCI]
   34. Chen SC, Hao SP, Tsang NM, Lee KF. (2001) Nasopharyngeal lith. Otolaryngol Head Neck Surg 125:576-578. [SCI]
   35. ´¿¶­©ú¡B ³¯¦Ú­b¡B³¯¨Z«°¡BªL«T«Û¡B«À¾ÇµØ¡B§õ²Ô»¨¡B´¿®¶²h¡C(2002)  ¹q¸£Â_¼h¼ÒÀÀÄá¼vÀ³¥Î©ó¥þ¸£¯á´Õ·Ó®g·Ó³¥¤§³]­p»Pµû¦ô¡C©ñ®gªvÀø»P¸~½F¾ÇÂø»x ²Ä¤E¨÷²Ä¤@´Á²Ä23-30­¶¡C   
   36. Ping-Ching Pai, Chi-Cheng Chuang, Kuo-Chen Wei, Ngan-Ming Tsang*, Chen-Kan Tseng, Chen-Nen Chang. (2002) Stereotactic Radiosurgery for Locally Recurrent Nasopharyngeal Carcinoma. Head and Neck 24:748-753. [SCI] [*Corresponding author]
   37. Hao SP, Tsang NM, Chang CN. (2002) Salvage surgery for recurrent nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 128:63-67. [SCI]
   38. Hao SP, Tsang NM. (2002) The role of supraomohyoid neck dissection in patients of oral cavity carcinoma. Oral Oncol. 38:309-312. [SCI]
   39. Chang KP, Hao SP, Lin SY, Tsao KC, Kuo TT, Tsai MH, Tseng CK, Tsang NM* (2002). A Lack of Association Between p53 Mutations and Recurrent Nasopharyngeal Carcinomas Refractory to Radiotherapy. Laryngoscope. 112: 2015-2019. [SCI] [*Corresponding author] (NSC87-2314-B182A-003)

    

   Chapter:
   Hao, S-P & Tsang N-M. (2009) Nasopharyngeal carcinoma. In Petruzzelli G. (Ed.), Practical Head and Neck Oncology. (pp. 175-190). Plural Publishing, San Diego, USA.

1. (poster) Tseng, C. K., Tsang N.M. Tsai J. S., Pai P.C., Chang J.T.C., and Chen W.C. (Jun. 10-12, 2002, London, UK) Radiotherapy to primary CNS germinoma: how large an irradiated volume is justified for tumor control? 10th International Symposium on Pediatric Neuro-Oncology.
2. (oral) Chen Kan Tseng, Ping Ching Pai, Tung Chieh Chang, Kuo Chen Wei, Chen Nen Chang (Dec. 4-6, 2003, Seoul, S. Korea) IMRT For high grade glioma. The 2nd Meeting for Asian Society for Neuro-Oncology.
3. (poster) Chen Kan Tseng, Ng Ming Tsang, Kuo Chen Wei, Tang Her Jaing, Ping Ching Pai (Nov. 13-15, 2005 Taipei, Taiwan.) The Result of Medulloblastoma Treated With Radiotherapy in Supine Position. 4th Asian Society of Neuro-Oncology,
4. (poster) Chen Kan Tseng, Ng Ming Tsang, Kuo Chen Wei, Tang Her Jaing, Ping Ching Pai (Jun. 6-8, 2006, Nara, Japan) The result of medulloblastoma treated with radiotherapy with or without chemotherapy. 12th International Symposium on Pediatric Neuro-Oncology.
5. (poster) Chen Kan Tseng, Kuo Chen Wei, Ng Ming Tsang, Ping Ching Pai, Shih Ming Jung (Mar. 30-31, 2007, Warsaw, Poland) Methylated methylguanine DNA methyltransferase can not predict the prolonged survival in our recurrent glioma patients received temozolomide as salvage treatment, 3rd. Progress in central nervous system malignancies.
6. (oral) Chen Kan Tseng (Dec. 1, 2007, Kaohsiung, Taiwan) Promoter methylation status of methyl-guanine DNA methyltransferase (MGMT) vs. prognosis in glioma patients received gliadel wafer implantation, Annual meeting of Taiwan Neuro-Oncology Society.
7. (poster) Chen Kan Tseng, Ping Ching Pai, M.D., Shinn-Yn Lin, M.D., Tang Her Jaing, M.D. (Jun. 29- Jul. 2, 2008, Chicago, USA) Treatment Outcome of CNS Germinoma by Chemoradiation. The 13th International Symposium on Pediatric Neuro-Oncology.
8. (poster) Chen Kan Tseng, Tang Her Jaing, M.D. (Jun. 20- Jun. 23, 2010, Vienna, Austria) A pilot study of less-extensive radiotherapy and chemotherapy in patients with stage M0/1 supratentorial PNET. The 14th International Symposium on Pediatric Neuro-Oncology.